Stomach Neoplasms: all 2,914 studies
Page 9 of 30. Open to participants first (880), then studies with results posted, then the rest; newest registration first within each.
- ctDNA Screening in Advanced HER2 Positive Gastric CancerRecruitingNCT04520295
- Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian CancerRecruitingNCT04519151Phase 2
- Methylation Analysis of Circulating Tumor DNA in Gastric CancerNot yet recruitingNCT04511559
- Oxaliplatin Combined With S-1(SOX) Neoadjuvant Chemotherapy for Different Cycles in Patients With Gastric CancerRecruitingNCT04483076Phase 3
- HIPEC + FLOT vs. FLOT Alone in Patients With Gastric Cancer and GEJ (PREVENT)RecruitingNCT04447352Phase 3
- Laparoscopic Versus Open Lower Mediastinal Lymphadenectomy for Esophagogastric Junction CancerRecruitingNCT04443478
- BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid TumoursRecruitingNCT04421820Phase 1/2
- Patient-Derived Xenografts to Reduce Cancer Health DisparitiesRecruitingNCT04410302
- FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction AdenocarcinomaRecruitingNCT04393584Phase 2/3
- A Study of Sigvotatug Vedotin in Advanced Solid TumorsRecruitingNCT04389632Phase 1
- Dragon III-Phase 3: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric CancerNot yet recruitingNCT04384601Phase 3
- CONFIRM: Magnetic Resonance Guided Radiation TherapyRecruitingNCT04368702Not applicable
- Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric CancerRecruitingNCT04345770Phase 2
- Study to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With GC/GEJCRecruitingNCT04342910Phase 3
- PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric CancerRecruitingNCT04329494Phase 1
- A Phase II Trial of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With ChemoradiationRecruitingNCT04308837Phase 2
- Reduced Port Laparoscopic Gastrectomy for Gastric CancerRecruitingNCT04295473Not applicable
- Surgical TreAtment for Obesity Related Disease and Onco-Metabolic SurgeryRecruitingNCT04284943Not applicable
- Anlotinib Plus Toripalimab as First-line Treatment for Advanced Gastric Cancer With ECOG 2 (APICAL-GC)RecruitingNCT04278222Phase 2
- Radiation Therapy for the Treatment of Metastatic Gastrointestinal CancersRecruitingNCT04221893Not applicable
- Aspirin Use for Gastric Cancer Prevention in the Early Gastric Cancer PatientsRecruitingNCT04214990Phase 3
- EsophaCap for the Detection of Early Esophageal CarcinomaRecruitingNCT04214119
- Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)RecruitingNCT04198766Phase 1/2
- The GAstric Precancerous Conditions StudyRecruitingNCT04191551
- AG & IM in CA Stomach ProtocolRecruitingNCT04184960
- Preoperative Intravenous Iron Therapy in Patients With Gastric CancerNot yet recruitingNCT04168346Phase 4
- Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid MalignanciesRecruitingNCT04149691Phase 1
- A Trial of Total Versus Partial Omentectomy for Advanced Gastric Cancer in GastrectomyRecruitingNCT04108494Not applicable
- Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric CancerRecruitingNCT04107077Phase 2
- Screening of Gastric Cancer Via Breath Volatile Organic Compounds by Hybrid Sensing ApproachRecruitingNCT04022109
- Samples Procurement for Colorectal Cancer, Gastric Cancer, and Non-malignant DiseaseRecruitingNCT03972956
- Docetaxel Versus Oxaliplatin as Addition to S-1 for Stage II / III Gastric AdenocarcinomaRecruitingNCT03961867Phase 3
- Standard Versus Super-extended Lymphadenectomy After Neo-adjuvant Chemotherapy for Gastric CancerRecruitingNCT03961373Phase 3
- S-1 for 9 Months Versus 1 Year for Stage II Gastric Cancer (SMAC）RecruitingNCT03941561Phase 3
- Prophylactic Surgery Plus HIPEC With CO2 in Patients Affected by Gastric Carcinoma.GOETH StudyRecruitingNCT03917173Not applicable
- Gastric Cancer Prevention for Indigenous PeoplesRecruitingNCT03900910Not applicable
- Endoscopic Submucosal Dissection Versus Surgery in the Treatment of Early Gastric CancerNot yet recruitingNCT03857737Not applicable
- Neoadjuvant FOLFIRINOX in the Treatment of Locally Advanced Gastric CancerRecruitingNCT03825861Phase 2
- Intravital Microscopy in Human Solid TumorsRecruitingNCT03823144Not applicable
- Individually Tailored Strategies for the Precision Prevention of Gastric Cancer and Colorectal Cancer in the CommunityEnrolling by invitationNCT03793335
- Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid TumorsRecruitingNCT03740256Phase 1
- Tumor Cell and DNA Detection in the Blood, Urine, and Bone MarrowRecruitingNCT03551951
- Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal MalignanciesRecruitingNCT03539822Phase 1/2
- A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid TumorsRecruitingNCT03526835Phase 1/2
- The Analysis of Immuno-Nutrition Index in Advanced Gastric Cancer Receiving Preoperative TreatmentsRecruitingNCT03493880
- A Phase I/II Study of Regorafenib Plus Avelumab in Solid TumorsRecruitingNCT03475953Phase 1/2
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruitingNCT03452774
- Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable FactorRecruitingNCT03399253Phase 2/3
- Trial for Application of Laparoscopic Total Gastrectomy With Lymph Node Dissection for Gastric Cancer (KLASS-06)RecruitingNCT03385018Not applicable
- XELOX Plus Apatinib vs XELOX as Post-operative Chemotherapy in Locally Advanced Gastric Signet Ring CarcinomaNot yet recruitingNCT03355612Phase 3
- Combination of TATE and PD-1 Inhibitor in Liver CancerRecruitingNCT03259867Phase 2
- Predicting Biomarker of Gastric Cancer Chemotherapy ResponseRecruitingNCT03253107
- Surveillance of Patients With Precancerous Lesions of the StomachRecruitingNCT03250091
- Apatinib as the First-Line Therapy in Elderly Locally Advanced or Metastatic Gastric CancerRecruitingNCT03219593Phase 2
- Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 PatientsRecruitingNCT03190941Phase 1/2
- APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsRecruitingNCT03175224Phase 2
- Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric CancerRecruitingNCT03161522Phase 2
- A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid TumorsRecruitingNCT03129139Phase 1
- Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid TumorRecruitingNCT03093688Phase 1/2
- A Predictive Model Based on Narrow Band Imaging for Early Gastric Cancerous LesionsNot yet recruitingNCT02968069Not applicable
- Institut Paoli Calmettes Cardia Cancer DatabaseRecruitingNCT02869477
- Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid CancersRecruitingNCT02838836
- The Safety, Feasibility and Oncological Outcomes of Laparoscopic Completion Total Gastrectomy for Remnant Gastric CancerEnrolling by invitationNCT02792881Not applicable
- Feasibility of the LUM Imaging System for Detection of Gastrointestinal CancersRecruitingNCT02584244Phase 1/2
- Biomoleculars Markers of Sensitivity to Pre- and Post-operative Chemotherapy of Gastric and Cardia Adenocarcinomas: a Pilot StudyRecruitingNCT02491840Not applicable
- Cancer Experience Registry (CER) for Cancer Patients and CaregiversRecruitingNCT02333604
- Phase I Study of Sorafinib With Folfox4 as First-line Treatment in Advanced/Metastatic Gastric CancerAvailableNCT02209441
- Stereotactic Body Radiation Therapy (SBRT) for Unresectable Liver MetastasesRecruitingNCT02185443Phase 2
- "Phase III Randomized Trial Comparing D2 vs D3 Lymphadenectomy With Gastric Cancer Following Neoadjuvant ChemotherapyRecruitingNCT02139605Not applicable
- Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer MortalityRecruitingNCT02047994Phase 4
- Integrated Cancer Repository for Cancer ResearchRecruitingNCT02012699
- Tissue Procurement and Natural History Study of Patients With Malignant MesotheliomaRecruitingNCT01950572
- Compare Adjuvant Chemotherapy of Docetaxel/Capecitabine/Oxliplatin Versus Capecitabine/Oxaliplatin in Advanced Gastric Cancer at Stage IIIb and IV(KCSG ST15-08): TRIUMPHRecruitingNCT01935778Phase 3
- Adjuvant Capecitabine Versus Observation Alone in Curatively Resected Stage IB Gastric Cancer((KCSG ST14-05): CATALYSISRecruitingNCT01917552Phase 3
- Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of CancerRecruitingNCT01915225
- The Gastric Cancer Foundation: A Gastric Cancer RegistryRecruitingNCT01514045
- Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or BiopsyRecruitingNCT01416714
- Clinical & Pathological Studies of Upper Gastrointestinal CarcinomaRecruitingNCT01048281
- Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer PatientsRecruitingNCT00899626
- Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic TumorsRecruitingNCT00722228Phase 1/2
- Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2TerminatedNCT05980416Phase 1Results posted
- Blood Tests for Gastritis and Gastric NeoplasmsCompletedNCT05883345Results posted
- NUC-3373 in Combination With Other Agents in Patients With Advanced Solid TumoursTerminatedNCT05714553Phase 1/2Results posted
- Study of [18F]FAPI-74 PET in Patients With Gastrointestinal CancersCompletedNCT05641896Phase 2Results posted
- A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid TumorsTerminatedNCT05572684Phase 1/2Results posted
- A Study of Total Neoadjuvant Chemotherapy With FLOT VS Standard Perioperative FLOT in Patients With Gastric or GEJ CancerTerminatedNCT05567835Phase 2Results posted
- Study of SBRT/Olaparib Followed by Pembrolizumab/Olaparib in Gastric CancersCompletedNCT05379972Phase 2Results posted
- A Study of IMU-131 (HER-Vaxx) in Combination With Chemotherapy or Pembrolizumab in Patients With Metastatic HER2/Neu Over-Expressing Gastric Cancer (nextHERIZON)TerminatedNCT05311176Phase 2Results posted
- Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)CompletedNCT05259696Phase 1/2Results posted
- Nanatinostat Plus Valganciclovir in Advanced EBV+ Solid Tumors and in Combination With Pembrolizumab in EBV+ RM-NPCTerminatedNCT05166577Phase 1Results posted
- Propofol EC50 for Inducing Loss of Consciousness in General Combined Epidural AnesthesiaCompletedNCT05124704Not applicableResults posted
- A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)CompletedNCT05104567Phase 2Results posted
- A Safety and Activity Study of SBT6050 in Combination With Other HER2-directed Therapies for HER2-positive CancersTerminatedNCT05091528Phase 1/2Results posted
- A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid TumorsTerminatedNCT05070247Phase 1/2Results posted
- MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)CompletedNCT05007106Phase 2Results posted
- Nutrition in Gastroenteropancreatic Neuroendocrine TumorCompletedNCT04986085Results posted
- A Study of Amivantamab in Participants With Previously Treated Advanced or Metastatic Gastric or Esophageal CancerTerminatedNCT04945733Phase 2Results posted
- Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)-China ExtensionCompletedNCT04882241Phase 3Results posted
- Study to Assess the Efficacy and Safety of Lanreotide Autogel® in Chinese Participants With GEP-NETsCompletedNCT04852679Phase 3Results posted
- Safety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular CarcinomaCompletedNCT04798781Phase 2Results posted